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Abstract
Background: TMEM16A (Anoctamin 1; ANO1) is an eight transmembrane protein that functions as a calcium-
activated chloride channel. TMEM16A in human exhibits alternatively spliced exons (6b, 13 and 15), which confer
important roles in the regulation of channel function. Mouse Tmem16a is reported to consist of 25 exons that
code for a 956 amino acid protein. In this study our aim was to provide details of mouse Tmem16a genomic
structure and to investigate if Tmem16a transcript undergoes alternative splicing to generate channel diversity.
Results: We identified Tmem16a transcript variants consisting of alternative exons 6b, 10, 13, 14, 15 and 18. Our
findings indicate that many of these exons are expressed in various combinations and that these splicing events
are mostly conserved between mouse and human. In addition, we confirmed the expression of these exon variants
in other mouse tissues. Additional splicing events were identified including a novel conserved exon 13b, tandem
splice sites of exon 1 and 21 and two intron retention events.
Conclusion: Our results suggest that Tmem16a gene is significantly more complex than previously described. The
complexity is especially evident in the region spanning exons 6 through 16 where a number of the alternative
splicing events are thought to affect calcium sensitivity, voltage dependence and the kinetics of activation and
deactivation of this calcium-activated chloride channel. The identification of multiple Tmem16a splice variants
suggests that alternative splicing is an exquisite mechanism that operates to diversify TMEM16A channel function
in both physiological and pathophysiological conditions.
Background
Alternative splicing of pre-mRNAs is a powerful regula-
tory mechanism that can increase mRNA transcript vari-
ety and effect functional diversification of proteins [1].
Within the cardiovascular system, alternative splicing
affects cardiac function by regulating proteins involved in
cellular excitation, including ion channels [2-8].
Calcium-activated chloride currents have been recorded
in cardiac muscle cells from various species including
mouse [9], and play an important role in the cardiac action
potential [10-12]. In 2008, three independent groups iden-
tified Tmem16a as a strong candidate gene to encode (or
at least a major component of) a calcium-activated chlor-
ide channel [13-15]. Tmem16a belongs to a family of ten
mammalian paralogs (Tmem16 (a-h, j-k)) that are highly
conserved membrane spanning proteins. In recombinant
expression systems, Tmem16a (or Ano1) and Tmem16b
(or Ano2) generate calcium-activated chloride currents
[13-18] with similar biophysical and pharmacological
properties to currents recorded from native tissues [19].
We and others have identified Tmem16a expression in
mouse and human heart [20,21].
The human TMEM16A gene exhibits three alternatively
spliced exons (6b, 13 and 15) as well as an alternative tran-
scription start site [13]. Ferrera et al. reported that the bio-
physical properties of human TMEM16A are regulated by
alternative splicing and TMEM16A splice variants form
functional channels that display different properties [22].
The alternative exon 6b (encoding 22 amino acids) may
play an important role in the regulation of the TMEM16A
channel by calcium, since exclusion of this exon increases
the calcium sensitivity of the channel ~ 4-fold [22]. Exon
13, encoding 4 amino acids, contributes significantly to
TMEM16A channel kinetics, since exclusion of this exon
significantly reduces the voltage dependence of activation
[22]. A recent study showed that exon 15 (encoding 26
amino acids) exclusion results in significantly faster
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zone et al, showed significant differences in expression of
alternatively spliced TMEM16A exons in patients with dia-
betic gastroparesis when compared to non-diabetic con-
trols [23]. Therefore, it appears that alternative splicing of
human TMEM16A plays an important role in the regula-
tion of calcium-activated chloride channel function.
The reported mouse Tmem16a gene [GenBank: NC_
000073] is composed of 25 exons that code for a 956
amino acid protein [GenBank: NP_848757]. Unlike
human, mouse Tmem16a, as annotated, does not contain
alternative exons 6b, 13 or 15. We and others however,
have reported that Tmem16a transcripts containing these
alternative exons are expressed in mouse stomach, intes-
tine [24] and vascular [25] smooth muscle tissues. It is
likely that alternative splicing of Tmem16a transcript in
mouse may lead to a number of different TMEM16A
channel proteins with altered biophysical properties simi-
lar to human TMEM16A [22,23]. In this study our aim
was to provide detailed information of the structure of
the mouse Tmem16a gene and to investigate if Tmem16a
transcript undergoes alternative splicing to generate
channel diversity in mouse heart. This study demon-
strates that the structure of Tmem16a gene is signifi-
cantly more complex than previously indicated. The
complexity is especially evident in the region containing
exons 6 through 16. Determining the variation of
Tmem16a transcript expression in heart is an important
foundation for future studies of the physiological role of
Tmem16a channels in heart.
Methods
RNA isolation and RT-PCR
Total RNA was isolated from mouse tissues using TRIzol
reagent (Invitrogen, Carlsbad, CA). Human heart RNA
was purchased from Agilent Technologies (Santa Clara,
CA). First-strand cDNA was prepared from 1 μgo fR N A
using oligo(dT)(12-18) primer and Superscript II reverse
transcriptase (Invitrogen). AmpliTaq Gold
® PCR reagent
(Applied Biosystems, Foster City, CA) was used to
amplify each of the Tmem16 paralogs and Tmem16a
splice variants. PCR primers were designed using the
mouse and human Tmem16a mRNA sequences [Gen-
Bank: NM_178642 and GenBank: NM_018043]. Details
of the primer sets used are provided in additional file 1,
Table S1 and Table S2). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as a control for
cDNA integrity. No template PCR reactions served as
controls for primer contamination. PCRs were performed
in a 2720 Thermal Cycler (Applied Biosystems). Amplifi-
cation consisted of 95°C for 10 min, then 35 cycles of
95°C for 15 sec, Ta for 20 sec and 72°C for 30-60 sec, fol-
lowed by a final step at 72°C for 7 min.
Splice variant identification, sequencing and
bioinformatics
PCR products were resolved on 2-3% super fine agarose
(Amresco, Solon, OH) gels along with a 100 bp molecu-
lar weight marker. Tmem16a amplification products
were either purified (QIAquick Gel Extraction Kit, Qia-
gen, Valencia, CA) or TA cloned into the pcDNA3.1
vector (Invitrogen). All fragment sequencing was per-
formed at the Nevada Genomics Center. Nucleotide and
protein sequences were analyzed using Vector NTI ver-
sion 11 software (Invitrogen) and BLASTN software at
the National Center for Biotechnology Information
(NCBI) database http://www.ncbi.nlm.nih.gov/BLAST/.
Transmembrane regions were predicted using the CBS
TMHMM Server v 2.0 http://www.cbs.dtu.dk/services/
TMHMM/ and TMpred http://www.ch.embnet.org/soft-
ware/TMPRED_form.html programs. The TAndem
S p l i c eS i t eD a t a B a s e( T a s s D B 2) http://gen100.imb-jena.
de/TassDB2/ was used to confirm alternative tandem
splice sites in mouse and human Tmem16a. The Scan-
site database http://scansite.mit.edu/motifscan_id.phtml
was used to identify motifs in the TMEM16A alternative
splice variants.
Results and Discussion
Tmem16a genomic structure is highly conserved in
mouse and human
Genomic sequences for human [GenBank: NC_000011)
and mouse [GenBank: NC_000073] Tmem16a were com-
pared with their respective RNA sequence [GenBank:
NM_018043 and NM_178642]. The reported mouse
Tmem16a gene is composed of 25 exons, however, our
analysis has revealed that mouse Tmem16a gene consists
of at least 29 exons, ranging in size from 12 bp to 1621
bp. Table 1 provides details of mouse Tmem16a gene
structure, including the number of exons, exon and
intron size, 5’ donor and 3’acceptor splice site sequences.
The exon sizes of human TMEM16A are also provided
for comparison purposes. The exon-intron junctions of
Tmem16a comply with the consensus dinucleotide GT-
AG rule. The number and size of each exon in mouse
Tmem16a gene are highly conserved with human
TMEM16A. There is some divergence between mouse
and human Tmem16a genes at the 5’ and 3’ termini. For
example, in mouse, exon 1 and exon 1b differ from
human. The putative translational initiation codon of
mouse and human Tmem16a are located in exon 1b and
exon 1 respectively. The nucleotides adjacent to the
initiator codons (mouse; GCCACCATGA and human;
GCCACGATGA), constitute a favorable Kozak consen-
sus initiation site [26]. Human TMEM16A has been
reported to exhibit alternative splicing [13]. This study
indicates that Tmem16a in mouse also exhibits multiple
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Page 2 of 13Table 1 Genomic Organization of Tmem16a
Human Mouse
Exon
number
Exon size
(bp)
Exon
number
Exon size
(bp)
3’ Acceptor and 5’ Donor splice site sequences Intron
size (bp)
1 413 1 119 CAGGTG gtagga ~59,580
1b 146 ttgcag ACGCCA———————————————————GGCACG
gtgagt
8,958
2 333 2 333 tcacag TTGCTG———————————————————GAGGAT
gtgagt
12,229
3 99 3 99 ctctag ACCAAA———————————————————AAGAAG
gtgagt
1,264
4 152 4 152 ccacag GTGTAC————————————————————ACACCT
gtgagt
1,340
5 55 5 55 ctgcag ATTCGA————————————————————ACAATA
gtgagt
3,649
6 52 6 52 ccctag GTCTAT———————————————————GCATGG
gtaagg
1,862
6b 66 6b 66 aaacag GGCAAG——————————————————AATACG gtaaga 495
7 56 7 56 ttaaag GTATCA————————————————————CACGAT
gtaagt
3,274
8 42 8 42 tcacag GGGGAC——————————————————AGGAAA gtaagt 6,143
9 65 9 65 ccccag CTCCTG————————————————————GGTCAG
gtaagt
1,290
10 135 10 135 gcatag GAAATA———————————————————CCCCAG
gtaggc
3,318
11 161 11 161 ttacag TATGGA————————————————————TCTGGG
gtaagt
11,845
12 83 12 83 ctacag CTGCCA———————————————————GAGGAG
gtgagt
2,181
13 12 13 12 ccgcag GAAGCT———————————————————GTCAAG
gtttga
161
13b 120 ttccag CACCTT————————————————————CAGAGG
gtcagt
273
14 72 14 72 tctcag GATCAT———————————————————AAAGAG
gtacag
2,874
15 78 15 78 cctcag AAGTGC————————————————————AAATTG
gtactt
972
16 75 16 75 ttgcag ACCGAC————————————————————TTCATG
gtaagt
3,034
17 202 17 202 ctgcag ATCGCA————————————————————AGATTG
gtgagt
167
18 112 18 112 cctcag AGGTCC———————————————————AGGCCG
gtagga
434
19 58 19 58 tcccag GTTTGT———————————————————GAGGAG gtaata 1,892
20 101 20 101 ctacag TGTGCC————————————————————CATCCC
gtgagt
786
21 146 21 146 ctgcag GAAGAT———————————————————AAATGA
gtgagt
4,324
22 153 22 153 ctgcag TCATTC—————————————————————ACATCG
gtaagt
6,207
23 53 23 53 ctctag GCATCT—————————————————————ATTAAT
gtaagt
1,554
24 185 24 185 tggcag GCCTTT————————————————————CTGCAG
gtacta
2,635
25 106 25 106 ttgcag GTATAA—————————————————————TTCCAG
gtatgt
2,435
26 1809 26 1621 ctgcag AACCTG
Intron size refers to the intron following the exon listed in each row.
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Page 3 of 13alternative exons, which generates numerous isoforms
through alternative splicing of the primary transcript.
A close examination of the mouse Tmem16a genomic
sequence revealed that similar sequences to these human
exon variants (exons 6b, 13 and 15) could be identified
(Table 1). Additionally, a number of novel splicing events
were identified (Table 1) and the details of these tran-
script variants are outlined throughout this report.
Identification of Tmem16a splice variant expression in
mouse heart
RT-PCR was initially used to identify the expression of
Tmem16 paralogs in mouse heart using primers specific
for each of the Tmem16 family members (Additional
file 1, Table S1). In addition to Tmem16a, several other
Tmem16 transcripts were detected in mouse heart:
Tmem16c, d, e, f, h, j and k (Figure 1A). The expression of
Tmem16b and Tmem16g transcripts were not detected.
To determine if alternative exons, homologous to the
exons 6b, 13 and 15 of human TMEM16A [13], are also
expressed in mouse heart we performed RT-PCR analysis
of Tmem16a (Figure 1B). Primer sets ± exon 6b, ± exon
13 and ± exon 15 amplify fragments that differ in size
(± 66 bp, 12 bp and 78 bp, respectively) corresponding to
the size of the alternative exon. The amplification of two
fragments using ± exon 6b and ± exon 15 primers clearly
indicates that Tmem16a variants that either include or
exclude these alternative exons are expressed in mouse
heart (Figure 1B). The presence or absence of the alterna-
tive 12 bp micro-exon 13 is difficult to resolve by gel elec-
trophoresis, therefore additional primers were designed
that either hybridize within each of the alternative exons
to specifically amplify them or that span bordering exons
to exclude them (Figure 1C and Additional file 1, Table
S2). For example, Tmem16a transcripts lacking exon 15
(-exon 15) were selectively amplified using a primer that
spans the junction of exons 14 and 16. Similarly,
Tmem16a transcripts containing exon 15 (+exon 15) were
specifically amplified using a primer internal to exon 15.
RT-PCR gel analysis (Figure 1C) and fragment sequencing
confirmed that Tmem16a variants are expressed in mouse
heart that either exclude or include exon 6b, exon 13 and
exon 15, identical to those we identified in mouse gastro-
intestinal tissues [24].
A comparison of the amino acid sequences of mouse
and human alternative exons show a high similarity; the
four amino acids (EAVK) of exon 13 are 100% identical,
the 22 and 26 amino acids encoded by exon 6b and exon
15, share 95.5% and 80.8% identity, respectively. Consid-
ering the high percentage amino acid identity of these
exon between the two species, we can expect that the
regulatory properties attributed to these channel domains
in human [22,23], will most likely confer similar func-
tional roles in the mouse, in that, exon 6b may confer
calcium sensitivity, exon 13 may contribute to voltage
dependence and exon 15 may play a role in the activation
and deactivation kinetics of this calcium activated chlor-
ide channel. The inclusion of alternative exons 6b, 13
and 15 would result in additional amino acids in intracel-
lular channel domains and are not predicted to alter the
eight transmembrane topology of the TMEM16A
protein.
Tmem16a transcripts with combinations of alternative
exons 6b, 13 and 15 create diversity
A detailed investigation into the expression of various
alternative exon combinations has not been reported for
Tmem16a. To explore if different combinations of these
alternative exons exist in mouse and human heart, we
employed RT-PCR analysis to examine the region of the
Tmem16a transcript encompassing alternative exons 6b,
13 and 15 (Figure 2). Eight Tmem16a variants may be gen-
erated due to alternative combinations of exon inclusion
or exclusion (Figure 2A). RT-PCR analysis generated
Tmem16a transcripts of various molecular sizes expressed
in mouse and human heart (Figure 2B), corresponding to
different combinations of Tmem16a alternative exon 6b,
13 or 15 inclusion or exclusion. The complexity of alterna-
tive exon combinations is difficult to resolve by size analy-
sis alone, largely due to the micro exon 13 and two
possible fragments of the same size (Figure 2A). Thus, the
entire RT-PCR amplifications were cloned, and sequence
analysis of multiple clones confirmed that at least six dis-
tinct Tmem16a splice variants consisting of various com-
binations of exons 6b, 13 and 15 are expressed in mouse
and human heart.
Both mouse and human heart express the following
three exon combinations: Tmem16a (-6b, +13, -15),
Tmem16a (+6b, +13, -15), and Tmem16a (-6b, +13, +15).
We did not identify Tmem16a transcripts consisting of
exon 6b alone (+6b, -13, -15) or a Tmem16a variant con-
taining 6b and 15 but lacking exon 13 (+6b, -13, +15) in
either mouse or human heart. It appears, at least in heart,
that exon 6b is only expressed in the presence of exon 13.
However, we did identify Tmem16a transcripts containing
exon 15 in the absence of both exons 6b and 13 (-6b, -13,
+15) in mouse heart. Interestingly, a Tmem16a transcript
missing all three exons (-6b, -13, -15) was only identified
in mouse heart, in agreement with the reported Tmem16a
[GenBank: NM_178642] and although a human transcript
variant 2 (-6b, -13, -15) [GenBank: NR_030691] exists we
did not confirm its presence in human heart. All human
TMEM16A transcripts contained exon 13, in agreement
with [GenBank: NM_018043] (-6b, +13, +15). The largest
Tmem16a variant consisting of all three exons was con-
firmed by sequence analysis in human heart. Although
this Tmem16a variant was not confirmed in our screening
of mouse heart clones, we cannot rule out its existence
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Page 4 of 13Figure 1 Identification of alternative Tmem16a exons 6b, 13 and 15 in mouse heart. A. Expression of Tmem16 family members were
analyzed in mouse heart using RT-PCR primers specific for each of the ten Tmem16 paralogs. Amplification products were resolved on 2%
agarose gels alongside a 100 bp marker. Fragments of the expected molecular size indicated the expression of Tmem16a, c, d, e, f, h, j and k
paralogs in mouse heart. Tmem16b and g were not detected. B. Schematic representations of regions of Tmem16a RNA. Boxed numbers indicate
exons relative to the Tmem16a gene. Alternative exon 6b (66 bp), exon 13 (12 bp) and exon 15 (78 bp) in the mouse Tmem16a coding
sequence are highlighted. RT-PCR primers (± exon 6b, ± exon 13, ± exon 15), which amplify across each alternative exon are indicated. RT-PCR
gel analysis of exon 6b, 13 and 15 Tmem16a variants expressed in mouse heart. Primers ± exon 6b amplify a 367 and/or a 433 bp product,
primers ± exon 13 amplify a 165 and/or a 177 bp product, primers ± exon 15 amplify a 297 and/or a 375 bp product. The upper bands
correspond to Tmem16a variants that include the alternative exon and differ in size corresponding to the size of that exon. C. RT-PCR primer sets
that span exon boundaries to selectively amplify individual alternative exons are indicated. Gel analysis of Tmem16a fragments expressed in
mouse heart that either include or exclude exons 6b, 13 or 15. Each primer set yielded a single band of the expected size. RT-PCR products
were sequenced for confirmation.
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expected size of this variant, albeit much weaker than in
human (Figure 2B). Indeed, it is possible that different
mouse and human tissues may express different combina-
tions of these alternative exons, however, quantification of
our data would not provide more information since the
tissues examined in this study contain a mixed population
of cells. The deduced amino acid sequence of mouse
TMEM16A containing alternative exons combinations
(6b, 13 and 15) all read in-frame, indicating that these
alternative exons are additional channel components simi-
lar to those of human TMEM16A [22]. BLASTn searches
of dbEST and Refseq RNA databases identified a number
of mouse ESTs containing exon 6b and exon 13. Indeed,
one mouse EST [GenBank: BI151426] was identified for
the +6b, +13, -15 exon combination. EST supporting
query sequences were identified for mouse [GenBank:
BI685387] containing exon 13 alone (-6b, +13, -15). No
ESTs were found in mouse containing both exon 13 and
15, however this is the exon combination in human that
corresponds to TMEM16A [GenBank: NM_018043].
In addition to alternative exons 6b, 13 and 15, we also
identified a number of novel Tmem16a splicing events in
mouse and human heart; exon 10 and exon 14 exclusion,
the inclusion of a novel exon, and two intron retention
events.
Novel Tmem16a transcripts with exon 10 or exon 14
exclusion
We identified two previously unreported Tmem16a exon
skipping events, exon 10 and exon 14, in mouse and
human heart (Figure 3). Exclusion of exon 10 (135 bp)
in Tmem16a RNA would result in an in-frame deletion
of 45 amino acids in the channel protein. Exon 10
Figure 2 Multiple Tmem16a variants are expressed in heart due to different combinations of alternative exons 6b, 13 and 15. A.
Cartoon indicating eight possible Tmem16a transcript variants as a result of combinations of exon 6b, 13 or 15 inclusion and/or exclusion.
Dashed lines denote the exclusion of an alternative exon. Primers which span Tmem16a from exon 6 to exon 16, a region encompassing the
three alternative exons (shaded), generate transcripts of various sizes depending upon which exons are amplified. The expected sizes of RT-PCR
products are indicated. Tmem16a variant [GenBank: NM_178642] lacking all 3 exons is indicated (#). B. Gel analysis of Tmem16a RT-PCR
fragments ranging between 657 and 855 bp were amplified. 100 bp ladder (L).
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Page 6 of 13encodes a hydrophobic region predicted to be the first
transmembrane spanning domain of TMEM16A. There-
f o r e ,e x o n1 0e x c l u s i o nw o u l dr e s u l ti nac h a n g ei nt h e
transmembrane topology. We identified through sequen-
cing two different Tmem16a (-10) transcripts, in that
both transcripts lacked exon 6b and included exon 13,
however, they differed in whether or not exon 15
was included. This is highlighted in the cartoon in
Figure 3A. We employed an additional primer set to
specifically amplify Tmem16a (-10) variants (Figure 3A)
and sequence analysis confirmed the presence of these
transcript variants in mouse and human heart.
Sequence analysis revealed that the Tmem16a (-14)
variant included exons 6b and 13 and excluded exon 15
(Figure 3B). Exclusion of exon 14 (72 bp) in Tmem16a
RNA would result in an in-frame deletion of 24 amino
acids in the first intracellular loop of the TMEM16A
channel. A PKC site is present in exon 14 at position
S462 [GenBank: NP_848757] and one could speculate
that Tmem16a transcripts lacking exon 14 may encode
channels that differ in modulation by PKC. Likewise, the
expression of this variant was confirmed in mouse and
human heart using primers which specifically amplify
Tmem16a (-14) variants.
Tmem16a transcripts with a novel conserved exon 13b
Sequence screening of our Tmem16a clone library, iden-
tified an unusual Tmem16a transcript that excluded
alternative exons 6b, 13 and 15 yet contained an addi-
tional 120 nucleotides between exon 12 and exon 14.
Evaluation of Tmem16a genomic sequence revealed that
these 120 nucleotides are located within the 554 bp intro-
nic region between exon 13 and 14 (Figure 4A) and are
bordered by conserved ‘GT-AG’ acceptor and donor
splice sites [27]. We assigned the additional sequence in
this Tmem16a transcript as exon 13b. A close examina-
tion of the intronic sequence immediately upstream of
exon 13b identified a conserved mammalian “CURAY”
branchpoint sequence 18 nucleotides upstream of the 3’
splice site (Figure 4A). The branchpoint (A nucleotide) is
generally situated 18 to 40 nucleotides upstream of the 3’
splice site and plays an important role in identifying this
splice site [28,29]. An adjacent polypyrimidine tract,
which increases the efficiency of branchpoint utilization
[30], was also identified in this region (Figure 4A).
Together, these findings add support that this 120 bp
s e q u e n c ei sat r u ee x o n .I n c l u s i o no fe x o n1 3 bi nt h e
Tmem16a transcript would result in an in-frame addition
of 40 amino acids in TMEM16A. This region is rich in
hydrophobic leucine residues (12/40 residues being leu-
cines). It is not surprising then that hydropathy analysis
suggests that exon 13b inclusion may constitute an addi-
tional domain in the TMEM16A channel integral to the
membrane.
Considering that the exon structures of Tmem16a
are highly conserved amongst homologs, we investi-
gated if similar novel exons could be identified in
other species. A close examination of the genomic
Tmem16a sequence from rat, human and rhesus mon-
key [GenBank: NC_005100, GenBank: NC_000011,
GenBank: NC_007871,] revealed that similar sequences
to mouse Tmem16a exon 13b, bordered by conserved
splice sites could be identified. An alignment of the
corresponding amino acid sequence of these four spe-
cies (Figure 4B) demonstrates 97.6% overall consensus
with an identity of 41.5%. Specific primers designed to
amplify this novel exon in human heart were unable to
identify its expression. Whether or not this exon is
present in other human tissue types is unknown.
T h ee x p r e s s i o no ft h en o v e le x o n1 3 bi nm o u s eh e a r t
was investigated further using primer sets to specifically
amplify the 5’ and 3’ regions surrounding the 120 bp
exon (Figure 4C). Sequence analysis revealed some inter-
esting observations. First, we confirmed that exon 13b is
utilized in mouse heart. Secondly, exon 13b is present in
several Tmem16a transcripts that differ in whether they
also include or exclude alternative exons 13 or 15. Third,
retention of the introns surrounding exon 13b increases
the complexity of splicing in this region of Tmem16a
transcript. RT-PCR with the primer set 5’Exon13b, in
which primers bind within exon 11 and 13b produced
two amplification products (Figure 4C). Sequencing ana-
lysis indicated one Tmem16a fragment consisted of
exons 11, 12 and 13b and the other fragment consisted of
exons 11, 12, 13, 13b plus the entire 161 bp intronic
sequence between exon 13 and 13b (Figure 4C). The
3’Exon13b primer set, in which the primers hybridize
across exon 12/13b junction and within exon 16, yielded
three Tmem16a transcript fragments (Figure 4C). Two
fragments differ in exon 15 inclusion/exclusion exons 12,
13b, 14, ± 15, 16, and an unexpected fragment consisting
of exon 12, 13b, 14, -15, 16 plus the entire intronic
sequence (273 bp) between exon 13b and 14 (Figure 4C).
Intron retention events at the 5’ and 3’ of exon 13b are
certainly the result of alternative Tmem16a splicing and
not genomic contamination since the 5’Exon13b and
3’Exon13b primers span at least 14.4 kb and 4.4 kb of
genomic sequence, respectively.
The intron retention events at the 5’and 3’ of exon 13b
would introduce a premature stop codon in the Tmem16a
transcript, resulting in a truncated protein just after the
“EAVK” amino acids encoded by exon 13. The complete
retention of an intron in a mature transcript is one of the
least expected forms of alternative splicing and may occur
due to weak splice sites, cis-regulatory elements or short
intron lengths [31]. Indeed, the introns between exons 13
and 13b and between exon 13b and 14 are two of the
shortest in the Tmem16a genomic sequence (see Table 1).
O’Driscoll et al. BMC Molecular Biology 2011, 12:35
http://www.biomedcentral.com/1471-2199/12/35
Page 7 of 13Figure 3 Identification of Tmem16a novel exon 10 and exon 14 skipping events. Ai. Cartoon indicating Tmem16a variants as a result of
combinations of exon 10 exclusion, (-6b, -10, +13, +15) and (-6b, -10, +13, -15). Dashed lines denote the exclusion of an alternative exon. Aii.
RT-PCR with a specific primer set to verify the exclusion of exon 10 in mouse heart Bi. Cartoon indicating the Tmem16a variants as a result of
exon 14 exclusion, (+6b,+13, -14, -15). Bii. RT-PCR with a specific primer set to verify the exclusion of exon 14 in mouse heart.
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Page 8 of 13Figure 4 Identification of a novel exon 13b in Tmem16a. A. Cartoon representation of the novel exon 13b identified through sequence
analysis of a Tmem16a fragment amplified using primers that span exons 6 through 16. Exon13b (120 bp) is highlighted. The genomic region
between exon 13 and 14 is expanded to indicate the location of exon 13b, the splice and branch sites and the polypyrimidine tract. B.
Alignment of the 40 amino acids encoded by exon 13b of mouse with the corresponding residues identified in rat, human and rhesus monkey.
C. RT-PCR with primer sets 5’Exon13b and 3’Exon13b verified the expression of exon 13b in mouse heart. Cartoon of the amplification products
generated with these primers is shown. Primer set 5’Exon13b produced two fragments, the 290 bp fragment consisted of exons 11, 12 and 13b;
the 463 bp fragment consisted of exons 11, 12, 13 and13b plus the entire intronic sequence between exon 13 and 13b. The 3’E13b primer set
yielded three fragments. The 219 bp and 297 bp fragments included exons 12, 13b, 14, ± 15, 16, and the 492 bp fragment consisted of 12, 13b,
14, -15, 16 plus the intronic sequence between exon 13b and 14. The intron retention events are highlighted.
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Page 9 of 13Intron retention can result in the insertion of a premature
stop codon being introduced to the mature transcript
which may then be degraded by nonsense mediated decay
[32]. Indeed, decreasing the mRNA levels of certain genes
can be the purpose of alternative splicing [32]. However,
sometimes the retention of an intron in the coding region
can have a biological effect. For example, an intron retain-
ing isoform of the KCNMA1 gene, which encodes the
large conductance calcium-activated potassium channel
(BK), facilitates splice variant regulation which contributes
to structural and functional diversity of BK channel pro-
teins in hippocampal neurons [33,34].
Tmem16a transcript scanning assay reveals additional
novel splice variants
It is clear from our analysis that Tmem16a transcript
undergoes extensive splicing within the region between
exons 6 and 16. In addition, not all of these exon inclu-
sion/exclusion combinations are consistent between
mouse and human. Indeed splicing events occurring at
other regions of Tmem16a transcript may have impor-
tant functional implications. Thus, we profiled the entire
Tmem16a using overlapping RT-PCR primers to deter-
mine whether additional Tmem16a RNA splicing events
occur in mouse and human heart. The transcript
scanning assay and sequencing analysis revealed addi-
tional novel Tmem16a variants. These variants included
exon 18 exclusion in both mouse and human Tmem16a
and two alternative 3’ donor sites, Δ3’exon 1 and
Δ3’exon 21, in mouse. Details for mouse and human
Tmem16a are summarized in Tables 2 and 3.
Exon 18 is 112 nucleotides and the exclusion of this
exon shifts the encoded mouse TMEM16A out of frame
at amino acid I563 [GenBank: NP_848757], truncating the
protein from 956 to 596 amino acids. Exon 18 encodes the
fifth transmembrane spanning domain of TMEM16A [35]
and exclusion of exon 18 would result in a C-terminus
truncated TMEM16A protein containing four membrane
spanning domains (Figure 5A). Translation of mouse
TMEM16A yields a protein of ~110kDa. The exclusion of
exon 18 in the mouse transcript could result in a trun-
cated TMEM16A protein of ~60 -75 kDa (depending
upon which other alternative exons reported in this study
are also included or excluded). Interestingly, two indepen-
dent studies have reported an additional signal on Wes-
tern blots for TMEM16A [25,36] which were much lower
(~80 kDa) than the expected 110 kDa. From the results
presented in this study, it is possible that the lower mole-
cular weight band corresponds to an alternatively spliced
transcript that encodes a truncated TMEM16A protein.
Table 2 Mouse Tmem16a transcript scanning assay
Primer
Set
Oligonucleotid
sequences (5’® 3’)
Tmem16a
region
Size
(bp)
Alternative
exon(s) identified
A GAGGGAACCTCTGCGGACCGA (sense) Exons 1-3 613
GCCAGGGCGCATGGATCTTC (antisense) 610 Δ3’ Exon 1
B GGCCTGGAGTTGGAGAATGACG (sense) Exons 2-10 602
GTGTAGGCTCCAAGCCAGGCAA (antisense) 668 + Exon 6b
C GAACAACGTGCACCAAGGCCAAGTA (sense) Exons 6-16 699
TGGTGAAATAGGCTGGGAATCGGTC (antisense) 711 + Exon 13
777 + Exon 15
777 + Exons 6b + 13
789 + Exons 13 + 15
819 + Exon 13b
654 - Exons 10 +13 +15
705 - Exons 6b +13 -14
D TGGAGCACTGGAAACGGAAG (sense) Exons 12-20 625
ATACAGAGCTCCATGAGGCAGC (antisense) 637 + Exon 13
715 Exons 13 + 15
E ACCGACAAGGTGAAGCTGAC (sense) Exons 16-22 731
GACGCAACAAACAGGGTGAC (antisense) 619 - Exon 18
623 Δ3’ Exon 21
F GAAGTTTACGGCTGCATTGC (sense) Exons 17-24 719
ATGTAGAGGTACACCAGGCGAG (antisense)
G GCCTCATGGAGCTCTGTATCC (sense) Exons 20-26 767
CACCCAGTCCACAAAGTCACTC (antisense)
H TGGTATAACATCCTCAGAGGTG (sense) Exons 23-26 656
TCACTTGGTGATGGTCAGAA (antisense)
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are the result of wobble splicing occurring at donor splice
sites located in close proximity, commonly known as tan-
dem splice sites. Alternative splicing at tandem splice
sites occurs frequently in many species and can result in
subtle variations in transcripts and the proteins that they
encode [37]. Use of the Tmem16a Δ3’exon 1 splice site,
results in the exclusion of the last 3 nucleotides (GTG) of
exon 1. The mouse Tmem16a genomic sequence was
queried against the TassDB database of alternative tan-
dem splice sites [38], and the Δ3’exon 1 was recognized
as tandem splicing at donor splice site with the motif
GYNGYN. Indeed, a BLASTn search of the EST database
revealed 27 ESTs without this 3’ GTG and two ESTs that
contained it. This alternative splice event is not expected
to alter TMEM16A protein since exon 1 is non-coding.
Skipping of exon 1 and part of exon 2 has been reported
in human TMEM16A [13], however, Ferrera et al failed
to identify transcripts lacking this region [22] and consid-
ered that its splicing may be under the control of an
alternative promoter and influenced by certain physiolo-
gical or pathophysiological conditions. Indeed, a recent
study showed that a novel TMEM16A variant with an
alternative 5’ end is highly expressed in gastric smooth
muscle of patients with diabetic gastroparesis compared
with controls [23]. Apart from Δ3’exon 1 tandem splice
site, our study did not identify additional variation at the
5’end. The Δ3’exon 21 tandem splice site would result in
4 additional (GTGA) nucleotides at the 3’ end of exon
21. This is predicted to shift the protein out of frame at
amino acid M702 [GenBank: NP_848757], resulting in a
truncated TMEM16A protein with an altered C-terminus
Table 3 Human TMEM16A transcript scanning assay
Primer
Set
Oligonucleotide
sequences (5’® 3’)
Tmem16a
region
Size
(bp)
Alternative
exon(s) identified
A ACAGGCGGCCACGATGAGGGTC (sense)
GAGCCTGCATCCAGCGACGCC (antisense)
Exons 1-2 348
B AGGAGGGTGCAGCACAGCGA (sense)
ATTGGCCAGCAGGCTCGTGA (antisense)
Exons 2-7 582
648
+ Exon 6b
C GAGAACGACGTGTACAAAGGCCAAG (sense) Exons 6-16 714 + Exon 13
TTAGTGAGGTAGGCTGGGAACCGAT (antisense) 780 + Exons 6b + 13
792 + Exons 13 + 15
858 + Exons 6b +13 +15
579 - Exons 10 + 13
657 - Exons 10 + 13+15
708 + Exons 6b + 13 - 14
D ACTGACAAAGTGAAGCTGACA (sense) Exons 16-20 526
TGTTCTGGATCAGCTGTTTC (antisense) 414 - Exon 18
E TTTCCGTTCCTTCCGAATGG (sense) Exons 19-23 460
CTTCCCAATGCCTCTGAGGATA (antisense)
F TGTCACTGAGCTCCGAAGGCCG (sense) Exons 22-25 384
ACGATGACAAACGCCAGCCGG (antisense)
G AGTAAGAACGGGACCATGCACGG (sense) Exons 24-26 509
CGCTGGCATAGCTACAGGACGC (antisense)
Figure 5 Exon 18 deletion truncates the TMEM16A protein. A.
Cartoon indicating the Tmem16a variant as a result of exon 18
exclusion identified in the transcript scanning assay. RT-PCR with a
specific primer set (spanning the boundary of exons 17 and 19)
verified the exclusion of exon 18 in mouse heart. B. Exon 18 exclusion
truncates TMEM16A protein to 596 amino acids and the predicted
hydropathy profile is shown. Red boxes represent the four
transmembrane spanning domains, blue and pink lines represent
intracellular and extracellular locations respectively.
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Page 11 of 13of ~84 kDa. According to TassDB2 [39] this tandem
splice site is conserved in human, dog and chicken
Tmem16a sequence.
Distribution of novel Tmem16a alternative splice variants
in other tissues
This study focused on identifying Tmem16a splice variants
in heart. We extended this analysis to investigate if these
novel variants are expressed in other mouse tissues from
which a calcium-activated chloride current can be
recorded. Initially, we confirmed Tmem16a expression in
mouse brain, lung, stomach (antrum), small intestine,
colon, kidney and bladder tissues (data not shown). All
organs were dissected out with their attached vasculature.
Total RNA obtained from each of these organs therefore
contains a mixed population of cells. We then examined
the expression of the following exons: +6b, -10, +13, +13b,
-14, +15 and -18. The distribution of Tmem16a alternative
exon variants in these mouse tissues is summarized (Table
4). In addition to heart, all of the tissues examined express
the following variants; +6b, -10, +13, +13b and +15. The
-14 exon variant was only detected in heart, lung, small
intestine and colon. The -18 exon variant was detected in
all tissues examined apart from kidney. The molecular
diversity of Tmem16a may contribute to numerous pro-
teomic variations of TMEM16A channels that may fine-
tune channel functions in specific tissue types.
Conclusion
This report provides details of Tmem16a genomic orga-
nization and our analyses have detected previously uni-
dentified alternative exons. We identified Tmem16a
transcript variants consisting of different exon usage
events involving exons 6b, 10, 13, 14, 15 and 18. Many
of these exons are expressed in various combinations. A
number of other splicing events including a novel exon
13b, tandem splice sites of exon 1 and 21 and two
intron retention events were also identified. The alterna-
tive splicing events indentified here indicate that a var-
ied population of TMEM16A channels is expressed in
mouse heart and other tissues. The heart is a highly het-
erogeneous tissue composed of numerous cell types
tailored for specialized function. It is possible that many
Tmem16a variants can be co-expressed in the same
cells, or differentially distributed in distinct cell types
within the myocardium. Determining the localization of
different Tmem16a isoforms within tissues has impor-
tant implications with regard to the function of
Tmem16a. The functional consequence of TMEM16A
channel diversity remains to be determined. We can
speculate however, that TMEM16A variants would cre-
ate channels with altered biophysical properties, such as
that reported for exon 6b, 13 and 15 in TMEM16A
[22,23]. It is also possible that regulation of the channels
may be altered since several of these alternatively spliced
exons contain phosphorylation sites and interacting
domains, for example, PKC and CamKII (exon 18), PKA
(exon 6b), Erk-D domain (exon 10) and a Src-SH3
domain (exon 15). TMEM16A channels have been
shown to form homodimers [40,41], therefore, it is likely
that TMEM16A variants may interact with each other to
form functional channels in a similar manner to that
reported for the hERG family [42]. Another possibility is
that alternatively spliced isoforms may associate with
additional accessory proteins. It is evident from this
study that alternative splicing is an exquisite mechanism
that operates to diversify TMEM16A channel structures
by the combinatorial selection of alternatively spliced
events. Future recombinant expression of different
Tmem16a variants will reveal their physiological role.
Additional material
Additional file 1: Tables S1 and S2. TABLE S1: Primers used for RT-
PCR of Tmem16 paralogs. This table lists the GenBank accession
number for Gapdh and Tmem16 paralogs, the oligonucleotide sequence
of each primer and the expected amplicon sizes. TABLE S2: Primers
used for RT-PCR of Tmem16a exon variants. This table lists the primer
name, the oligonucleotide sequence of each primer, the annealing
temperature of each primer set and the expected amplicon sizes.
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Table 4 Distribution of Tmem16a exon variants in mouse tissues
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